Quick Answer
CervoMed Inc. reported Cash and Equivalents of $8.24 million for fiscal year 2025.
CervoMed Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $8.24M | -8.5% |
| 2024 | $9.00M | +15.5% |
| 2023 | $7.79M | +90.4% |
| 2022 | $4.09M | -89.0% |
| 2021 | $37.31M | +101.5% |
| 2020 | $18.52M | +30.6% |
| 2019 | $14.18M | +77.4% |
| 2018 | $7.99M | -10.2% |
| 2017 | $8.90M | +472.9% |
| 2016 | $1.55M | -22.2% |
| 2015 | $2.00M | -14.5% |
| 2014 | $2.34M | +816.4% |
| 2013 | $255.0K | -18.3% |
| 2012 | $312.1K | +217.0% |
| 2011 | $98.4K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.44M | +21.9% | +13.4% |
| June 30, 2025 | $8.32M | -16.9% | -20.8% |
| March 31, 2025 | $10.50M | +64.9% | +16.7% |
| December 31, 2024 | $9.00M | +15.5% | +16.2% |
| September 30, 2024 | $7.74M | -25.7% | -22.6% |
| June 30, 2024 | $10.01M | -33.3% | +57.2% |
| March 31, 2024 | $6.37M | -56.5% | -18.3% |
| December 31, 2023 | $7.79M | +90.4% | -25.2% |
- CervoMed Inc. showed a decrease of -8.5% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2011–2025 period, CervoMed Inc.’s cash and equivalents has grown by 8265.2% (from $98.4 thousand to $8.24 million).
- The most recent figure is from CervoMed Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: